» Articles » PMID: 21037087

Key Role of Glycoprotein Ib/V/IX and Von Willebrand Factor in Platelet Activation-dependent Fibrin Formation at Low Shear Flow

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2010 Nov 2
PMID 21037087
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

A microscopic method was developed to study the role of platelets in fibrin formation. Perfusion of adhered platelets with plasma under coagulating conditions at a low shear rate (250(-1)) resulted in the assembly of a star-like fibrin network at the platelet surface. The focal fibrin formation on platelets was preceded by rises in cytosolic Ca(2+), morphologic changes, and phosphatidylserine exposure. Fibrin formation was slightly affected by α(IIb)β(3) blockage, but it was greatly delayed and reduced by the following: inhibition of thrombin or platelet activation; interference in the binding of von Willebrand factor (VWF) to glycoprotein Ib/V/IX (GpIb-V-IX); plasma or blood from patients with type 1 von Willebrand disease; and plasma from mice deficient in VWF or the extracellular domain of GpIbα. In this process, the GpIb-binding A1 domain of VWF was similarly effective as full-length VWF. Prestimulation of platelets enhanced the formation of fibrin, which was abrogated by blockage of phosphatidylserine. Together, these results show that, in the presence of thrombin and low shear flow, VWF-induced activation of GpIb-V-IX triggers platelet procoagulant activity and anchorage of a star-like fibrin network. This process can be relevant in hemostasis and the manifestation of von Willebrand disease.

Citing Articles

Comparative proteomics reveals different protein expression in platelets in patients with alcoholic liver cirrhosis.

Haji Begli N, Freund C, Weiss K, Gotthardt D, Wannhoff A Proteome Sci. 2024; 22(1):3.

PMID: 38279183 PMC: 10811856. DOI: 10.1186/s12953-024-00227-y.


Maintaining sidedness and fluidity in cell membrane coatings supported on nano-particulate and planar surfaces.

Liu S, Li Y, Shi L, Liu J, Ren Y, Laman J Bioact Mater. 2023; 32:344-355.

PMID: 37927898 PMC: 10622627. DOI: 10.1016/j.bioactmat.2023.10.010.


Platelet accumulation in an endothelium-coated elastic vein valve model of deep vein thrombosis is mediated by GPIb-VWF interaction.

Baksamawi H, Alexiadis A, Vigolo D, Brill A Front Cardiovasc Med. 2023; 10:1167884.

PMID: 37180784 PMC: 10174463. DOI: 10.3389/fcvm.2023.1167884.


In Vitro Exposure to Glucose Alters the Expression of Phosphorylated Proteins in Platelets.

Suzuki M, Takeshita K, Kitamura Y, Kuribayashi M, Huang Z, Ichihara G Biomedicines. 2023; 11(2).

PMID: 36831080 PMC: 9953272. DOI: 10.3390/biomedicines11020543.


Procoagulant platelets: novel players in thromboinflammation.

Denorme F, Campbell R Am J Physiol Cell Physiol. 2022; 323(4):C951-C958.

PMID: 35993516 PMC: 9484986. DOI: 10.1152/ajpcell.00252.2022.


References
1.
Ruggeri Z, Dent J, Saldivar E . Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood. 1999; 94(1):172-8. View

2.
Endenburg S, Hantgan R, Lankhof H, Jerome W, Lewis J, Sixma J . On the role of von Willebrand factor in promoting platelet adhesion to fibrin in flowing blood. Blood. 1995; 86(11):4158-65. View

3.
Munnix I, Kuijpers M, Auger J, Thomassen C, Panizzi P, van Zandvoort M . Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation. Arterioscler Thromb Vasc Biol. 2007; 27(11):2484-90. PMC: 2376762. DOI: 10.1161/ATVBAHA.107.151100. View

4.
Dormann D, Clemetson K, Kehrel B . The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood. 2000; 96(7):2469-78. View

5.
Stefanini L, Roden R, Bergmeier W . CalDAG-GEFI is at the nexus of calcium-dependent platelet activation. Blood. 2009; 114(12):2506-14. DOI: 10.1182/blood-2009-04-218768. View